Trusted by 100,000+ International Patients
HIPEC: Italy vs United Arab Emirates
Cost, Quality & Recovery Compared
$25000
Italy Starting Cost
$45000
United Arab Emirates Starting Cost
See how these top medical tourism destinations compare for HIPEC.
| Comparison Factor | Italy | United Arab Emirates | Winner |
|---|---|---|---|
| Average Cost (in USD) | 25000 - 50000 | 45000 - 75000 | Italy |
| Success Rate (Min and Max) | 60% - 85% | 55% – 80% | Italy |
| Advanced Technology | Specialised European peritoneal surface malignancy centres use advanced CRS + HIPEC platforms, high-precision imaging (PET-CT, MRI), and multidisciplinary oncology teams. | Advanced CRS + HIPEC programs in specialised oncology centres with modern perfusion systems, PET-CT imaging, and minimally invasive/robotic-assisted surgical support. | Both Equal |
| JCI Accredited Hospitals | 10+ | 15+ | United Arab Emirates |
| Visa Process | Schengen Medical Visa (10 - 15 working days) | Medical Visa / Tourist Visa | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Italy and United Arab Emirates maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
Many hospitals in Italy are accredited by Joint Commission International (JCI) and certified under European healthcare quality standards.
HIPEC procedures in Italy are performed in specialised oncology centres with experienced surgical oncologists and multidisciplinary teams.
Clinical outcomes are supported by advanced cancer research, precision diagnostics, and personalised treatment protocols.
Healthcare in Italy is regulated under the Italian National Health Service (Servizio Sanitario Nazionale – SSN).
Many hospitals in the UAE are accredited by the Joint Commission International (JCI) and regulated by the MOHAP, DHA, and DOH authorities.
HIPEC outcomes depend on cancer type, stage, and completeness of cytoreduction; UAE centres follow international oncology protocols and multidisciplinary tumour board approaches.
Healthcare is regulated by the Ministry of Health & Prevention (MOHAP), Dubai Health Authority (DHA), and Department of Health (DOH - Abu Dhabi), ensuring strict standards for oncology care and surgical safety.
| Quality Metric | Italy | United Arab Emirates |
|---|---|---|
Accredited Hospitals | 15+ | 15+ |
CRS + HIPEC Availability | Yes | Yes |
ICU Support Level | Advanced (European tertiary cancer centres) | Advanced (tertiary & quaternary ICUs) |
Top Speciality Hospital Hubs | Milan, Rome, Bologna, Verona | Dubai, Abu Dhabi |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Specialised surgical oncologists
Several Italian centres perform CRS + HIPEC regularly and participate in European oncology research networks.
Highly specialised surgical oncologists
Moderate to high procedural volume
Surgical Oncologist
Burjeel Hospital for Advanced Surgery Dubai Sharjah • 5 Years
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Major Italian oncology hospitals have advanced surgical suites, HIPEC perfusion systems for heated chemotherapy, specialised oncology ICUs, modern diagnostic imaging, and integrated cancer care units including pathology, radiology, and chemotherapy services.
Luxury healthcare experience
Top hospitals in the UAE feature advanced operating theatres, specialised HIPEC perfusion machines, surgical oncology ICUs, robotic surgery platforms, and comprehensive cancer care services, including pathology, molecular diagnostics, and advanced imaging systems.
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after HIPEC in both countries.
HIPEC is performed during cytoreductive surgery, where heated chemotherapy circulates inside the abdominal cavity.
Patients are monitored closely in specialised oncology ICUs after surgery.
Doctors recommend staying locally after discharge for wound healing and early recovery monitoring.
Gradual recovery includes nutritional therapy, physiotherapy, and oncology follow-up visits.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
HIPEC is performed alongside cytoreductive surgery to remove visible tumours and treat microscopic disease within the abdomen.
Patients require ICU monitoring immediately after surgery.
International patients are advised to stay locally for recovery and follow-up care.
Recovery improves gradually with nutrition, physiotherapy, and oncology follow-up.
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
HIPEC recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your HIPEC journey.
Major surgery with extensive tumour removal may increase bleeding and infection risk.
Post-operative pain and swelling are expected and managed with clinical protocols.
Delayed healing may occur in patients with poor nutrition or advanced disease.
Possible bowel complications, leakage, or infection, depending on surgical complexity.
Heated chemotherapy may impact kidney function or bone marrow, requiring monitoring.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Patients diagnosed with peritoneal surface malignancies such as colorectal cancer with peritoneal metastasis, ovarian cancer, appendix cancer, mesothelioma, or pseudomyxoma peritonei who may benefit from cytoreductive surgery combined with heated intraperitoneal chemotherapy.
Patients with peritoneal malignancies such as colorectal cancer with peritoneal spread, ovarian cancer, appendix tumours, peritoneal mesothelioma, or pseudomyxoma peritonei who are suitable candidates for cytoreductive surgery with HIPEC.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your HIPEC journey.
Doctors evaluate the extent of peritoneal disease using the PCI scoring system.
Surgeons assess whether complete tumour removal (cytoreduction) is achievable.
Prepare for ICU recovery, hospital stay, and rehabilitation needs.
Budget for surgery, ICU care, medicines, and potential complications.
Schedule follow-up monitoring and further oncology treatment if needed.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
